Apple AirPods Pro 3 vs Signia Pure Charge&Go MaX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Apple AirPods Pro 3
The Apple AirPods Pro 3 is a budget-priced OTC hearing aid available at $250, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear device ranks #49 of 65 OTC hearing aids tested, placing it in the top 74% of its category. The standout performance area is music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during normal use. However, speech performance presents a more mixed picture: speech in quiet scores 2.3/5, falling 0.53 points below the category average, while speech in noise scores 1.8/5—above the category average but low in absolute terms. Own-voice comfort is a notable weakness at 1.9/5, scoring 0.61 points below the category average, which may affect how natural your own speech sounds while wearing the devices. The product showed meaningful improvement from tuning, with the normalized score rising from 3.2/5 to 3.8/5 after adjustment. The AirPods Pro 3 is best suited for users who prioritize music streaming quality and seamless Apple ecosystem integration over maximum speech clarity. Budget-conscious shoppers should note that several competitors in the same price range—including the Elehear Beyond and the previous-generation Apple AirPods Pro 2—achieved higher overall scores in our testing.
Choice

Signia Pure Charge&Go MaX
The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit